With a rapidly increasing number of GLP-1 drugs already being prescribed for conditions such as type 2 diabetes, obesity and kidney disease, these results suggest these medications could potentially be repurposed to reduce the risk of no-reflow in heart attack patients
BNIP3+ fibroblasts associated with hypoxia and inflammation predict prognosis and immunotherapy response in pancreatic ductal adenocarcinoma
Akrami A, Nikaein F, Babajafari S, et al
The platelet glycoprotein Ib-von Willebrand factor interaction activates the collagen receptor alpha2beta1 to bind collagen: activation-dependent conformational change of the alpha2-I domain
Gentle adjustments can help restore digestive comfort
On average, monotherapy and combination therapy patients had 7.7 and 6.1 physician visits, respectively, within the first year